Novo Nordisk A/S (NVO) Stock Price Today
Key Stats
- $170.11BMarket Cap
- 19,900,898Volume
- HealthSector
- $63.9852W High
- $35.2952W Low
- 114 DaysTypical Hold Time
- $184.60BEnterprise Value
- 4.65%Div Yield
- 47% Sell | 53% BuyTrading Activity
Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $63.98, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Most Recent News
Masonglory, INLIF, and Apimeds stocks surge on strategic deals and strong results
Masonglory Limited's shares soared over 300% following its share swap deal to acquire a 20% stake in an Austrian construction firm, expanding its business scope. INLIF Limited gained about 74% after reporting strong first-half fiscal 2026 results wit...

Crusoe cancels $1.25B turbine deal with Boom Supersonic, shifting AI data center power strategy.
Crusoe, a Denver-based AI data center startup, has ended its $1.25 billion deal to buy 29 natural gas turbines from Boom Supersonic, which had planned to supply stationary power plants. Crusoe, originally a bitcoin miner using excess natural gas, now...

Automattic CEO Matt Mullenweg rebuilds board after failed ousting attempt, regains control swiftly.
Automattic CEO Matt Mullenweg has swiftly regained control of the company after a failed board attempt to oust him, replacing the entire board with a new, eclectic group including a sci-fi author and co-founders of the defunct social app IRL. The pre...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.